STOCK TITAN
  1. Home
  2. Sec-filings
  3. SRTA
  4. [Form 4] Strata Critical Medical, Inc. Insider Trading Activity

Strata Critical Medical (SRTA) CAO gets PSU shares; 34,015 withheld

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

On July 30, 2026, Cohen Amir, Chief Accounting Officer of Strata Critical Medical, Inc., received 41,786 and 27,420 shares of Class A common stock upon certification that performance goals were met on earlier performance-based restricted stock unit (PSU) awards. On July 31, 2026, 34,015 shares were withheld at $5.0900 per share to satisfy related tax withholding obligations.

Positive

  • None.

Negative

  • None.
Insider Cohen Amir
Role Chief Accounting Officer
Type Security Shares Price Value
Tax Withholding Class A common stock, $0.0001 par value per share F3 34,015 $5.09 $173K
Grant/Award Class A common stock, $0.0001 par value per share F1 41,786 $0.00 $0.00
Grant/Award Class A common stock, $0.0001 par value per share F2 27,420 $0.00 $0.00
Holdings After Transaction: Class A common stock, $0.0001 par value per share — 181,799 shares (Direct)
Footnotes (3)
  1. F1. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.
  2. F2. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
  3. F3. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
Shares from 2024 PSU grant 41,786 shares Class A common stock acquired on July 30, 2026 upon certification of 2024 PSU performance criteria (F1)
Shares from 2025 PSU grant 27,420 shares Class A common stock acquired on July 30, 2026 upon certification of 2025 PSU performance criteria (F2)
Shares withheld for taxes 34,015 shares Class A common stock withheld on July 31, 2026 to satisfy tax withholding obligations on PSU vesting (F3)
Tax withholding price $5.0900 per share Value used for withholding 34,015 shares to cover tax obligations on PSU vesting
performance-based restricted stock units ("PSUs") financial
"performance criteria underlying an award of performance-based restricted stock units ("PSUs")"
tax withholding obligations financial
"shares withheld by the Issuer to satisfy tax withholding obligations in connection"
Compensation Committee financial
"acquired upon the certification of the Compensation Committee of the Issuer's Board"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider equity transactions did SRTA report for Cohen Amir on July 30–31, 2026?
Cohen Amir received 41,786 and 27,420 SRTA Class A shares on July 30, 2026, from vested performance-based RSUs. On July 31, 34,015 shares were withheld at $5.0900 per share to cover tax obligations tied to that vesting.

Were any Strata Critical Medical (SRTA) shares sold on the open market in this Form 4?
No open-market sales are reported. The filing shows stock awards from vested PSUs and 34,015 shares withheld by the issuer at $5.0900 per share solely to satisfy tax withholding obligations connected to those vestings.

What PSU awards underlie Cohen Amir’s SRTA stock grants in this filing?
The stock grants relate to performance-based RSUs granted on March 8, 2024, and March 20, 2025. Shares vested when the Compensation Committee certified that performance criteria were satisfied, leading to the issuance of 41,786 and 27,420 Class A shares, respectively.

How many SRTA shares were withheld for taxes from Cohen Amir’s PSU vesting?
The issuer withheld 34,015 SRTA Class A shares at $5.0900 per share. According to the disclosure, this withholding was to satisfy tax withholding obligations that arose when performance-based RSUs vested and converted into common stock.

Does the SRTA Form 4 indicate the transactions were under a Rule 10b5-1 plan?
The Rule 10b5-1 checkbox is not marked, and no footnote references a trading plan. Reported activity consists of PSU-related share issuances and tax withholding, rather than pre-arranged open-market trades under a Rule 10b5-1 plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cohen Amir
(Last)(First)(Middle)
C/O STRATA CRITICAL MEDICAL, INC.
666 THIRD AVENUE, 25TH FLOOR
(Street)
NEW YORK NEW YORK 10017
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A common stock, $0.0001 par value per share07/30/2026A41,786(1)A$0188,394D
Class A common stock, $0.0001 par value per share07/30/2026A27,420(2)A$0215,814D
Class A common stock, $0.0001 par value per share07/31/2026F34,015(3)D$5.09181,799D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.
2. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
3. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
Remarks:
/s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR